1. World Health Organization. Global health sector strategy on viral hepatitis 2016–2021. Available at:www.who.int/hepatitis/strategy2016-2021/ghss-hep/en (accessed March 2018).
2. Treatment scale-up to achieve global HCV incidence and mortality elimination targets: a cost-effectiveness model;Scott;Gut,2017
3. Australian Government Department of Health: The Pharmaceutical Benefits Scheme. General statement for drugs for the treatment of hepatitis C. Available at:www.pbs.gov.au/healthpro/explanatory-notes/general-statement-pdf/general-statement-hepatitis-c.pdf (accessed March 2018).
4. Kirby InstituteAnnual Surveillance Report of HIV, viral hepatitis, STIs 2016Available at:https://kirby.unsw.edu.au/report/annual-surveillance-report-hiv-viral-hepatitis-stis-2016accessed March 2018).